These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 17429143)

  • 1. Orders of magnitude change in phenotype rate caused by mutation.
    Ao P
    Cell Oncol; 2007; 29(1):67-9; author reply 71-2. PubMed ID: 17429143
    [No Abstract]   [Full Text] [Related]  

  • 2. Cancer biology and Mr. Darwin.
    Gatenby R
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):67-68. PubMed ID: 28412279
    [No Abstract]   [Full Text] [Related]  

  • 3. Microsatellite instability.
    de la Chapelle A
    N Engl J Med; 2003 Jul; 349(3):209-10. PubMed ID: 12867603
    [No Abstract]   [Full Text] [Related]  

  • 4. Genetics of cancer predisposition and progression.
    Schwechheimer K; Cavenee WK
    Clin Investig; 1993 Jun; 71(6):488-502. PubMed ID: 8353410
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Snapshot: genetic mouse models of cancer.
    Zender L; Zuber J; Lowe SW
    Cell; 2007 May; 129(4):838. PubMed ID: 17512415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Cancer genetic predisposition: current events and perspectives in 2010].
    Stoppa-Lyonnet D; Stern MH; Soufir N; Lenoir G
    Pathol Biol (Paris); 2010 Oct; 58(5):324-30. PubMed ID: 20691548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations, evolution and the central role of a self-defined fitness function in the initiation and progression of cancer.
    Gatenby RA; Brown J
    Biochim Biophys Acta Rev Cancer; 2017 Apr; 1867(2):162-166. PubMed ID: 28341421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer: an epigenetic landscape.
    Dhanasekaran K; Arif M; Kundu TK
    Subcell Biochem; 2013; 61():399-417. PubMed ID: 23150260
    [No Abstract]   [Full Text] [Related]  

  • 9. The "aneuploidy-modified mutator-phenotype" theory of malignant tumors.
    Bignold LP
    Cell Oncol; 2008; 30(5):459. PubMed ID: 18791278
    [No Abstract]   [Full Text] [Related]  

  • 10. Genetic instability is not a requirement for tumor development.
    Bodmer W; Bielas JH; Beckman RA
    Cancer Res; 2008 May; 68(10):3558-60; discussion 3560-1. PubMed ID: 18483234
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppressors of the malignant phenotype.
    Mikkelsen T; Cavenee WK
    Cell Growth Differ; 1990 Apr; 1(4):201-7. PubMed ID: 2128032
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic potential of targeting haploinsufficient genes in cancer.
    Cheung KJ; Ebert BL
    Pediatr Blood Cancer; 2009 Aug; 53(2):131-2. PubMed ID: 19343773
    [No Abstract]   [Full Text] [Related]  

  • 13. Regulation of transformation and the cell cycle by p53.
    Zambetti GP; Quartin RS; Martinez J; Georgoff I; Momand J; Dittmer D; Finlay CA; Levine AJ
    Cold Spring Harb Symp Quant Biol; 1991; 56():219-25. PubMed ID: 1819488
    [No Abstract]   [Full Text] [Related]  

  • 14. Cancers exhibit a mutator phenotype: clinical implications.
    Loeb LA; Bielas JH; Beckman RA
    Cancer Res; 2008 May; 68(10):3551-7; discussion 3557. PubMed ID: 18483233
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The chromosomal basis of cancer.
    Duesberg P; Li R; Fabarius A; Hehlmann R
    Cell Oncol; 2005; 27(5-6):293-318. PubMed ID: 16373963
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumors with microsatellite instability: many mutations, targets and paradoxes.
    Perucho M
    Oncogene; 2003 Apr; 22(15):2223-5. PubMed ID: 12700658
    [No Abstract]   [Full Text] [Related]  

  • 17. The RET p.G533C mutation confers predisposition to multiple endocrine neoplasia type 2A in a Brazilian kindred and is able to induce a malignant phenotype in vitro and in vivo.
    Oliveira MN; Hemerly JP; Bastos AU; Tamanaha R; Latini FR; Camacho CP; Impellizzeri A; Maciel RM; Cerutti JM
    Thyroid; 2011 Sep; 21(9):975-85. PubMed ID: 21834681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Connecting Cancer to Its Causes Requires Incorporation of Effects on Tissue Microenvironments.
    DeGregori J
    Cancer Res; 2017 Nov; 77(22):6065-6068. PubMed ID: 28754675
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MedGenMed Hematology/Oncology conference report--plenary session: from genes to cells to metastasis. Highlights from the 2003 annual meeting of the American Association for Cancer Research.
    Mariani SM
    MedGenMed; 2003 Aug; 5(3):23. PubMed ID: 14600659
    [No Abstract]   [Full Text] [Related]  

  • 20. Molecular origins of cancer.
    Burstein HJ; Schwartz RS
    N Engl J Med; 2008 Jan; 358(5):527. PubMed ID: 18234758
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.